RelA promotes tumor growth, anti-apoptotic responses, and invasion by activating NF-κB signaling and regulating the expression of genes associated with cell proliferation and survival, such as Cyclin D1 and Bcl-240, 41. The gene discussed is CCND1; the disease is neoplasm.